Competition Between Plasminogen and Tissue Plasminogen Activator for Cellular Binding Sites

Cellular receptors for plasminogen and tissue plasminogen activator (t-PA) regulate plasminogen activation and cell-associated proteolytic activity. The characteristics of the interactions of both ligands with monocytes and monocyt-oid cell lines bear certain similarities, including affinity (kd app...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 82; no. 8; pp. 2433 - 2441
Main Authors Felez, Jordi, Chanquia, Carlos J., Fabregas, Pere, Plow, Edward F., Miles, Lindsey A.
Format Journal Article
LanguageEnglish
Published Washington, DC Elsevier Inc 15.10.1993
The Americain Society of Hematology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cellular receptors for plasminogen and tissue plasminogen activator (t-PA) regulate plasminogen activation and cell-associated proteolytic activity. The characteristics of the interactions of both ligands with monocytes and monocyt-oid cell lines bear certain similarities, including affinity (kd approximately 1 μmol/L) capacity and susceptibility to car-boxypeptidase treatment. Therefore, we have undertaken the present study to determine directly whether t-PA and plasminogen share common binding sites on cells. We found that recombinant human single-chain t-PA (rt-PA) could inhibit the binding of 125l-plasminogen to the cells and, conversely, plasminogen could inhibit 125l-rt-PA binding. This relationship was observed with 9 cell types, including both adherent cells and cells in suspension. In addition, under several conditions of cell treatment, plasminogen and t-PA receptor expression was modulated in parallel. Furthermore, molecules that have been implicated as candidate plasminogen receptors, gangliosides, and an α-enolase—related molecule, also interacted with t-PA. These results suggest that at least a component of the binding sites for plasminogen is shared with t-PA. Occupancy of these sites by either or both ligand(s) should result in arming the cells with the proteolytic activity of plasmin.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.V82.8.2433.2433